ShiraTronics Completes Australian Pilot Study Enrollment; Prepares for Pivotal Clinical Study February 6, 2024 Read More ›
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure November 2, 2023 Read More ›
Contego Medical Announces One-Year Outcomes From The Performance II Carotid Stent Trial November 1, 2023 Read More ›
Trinity Capital Inc. Provides $25 Million Growth Capital to Neuros Medical, Inc. October 31, 2023 Read More ›
Contego Medical Announces Start of Enrollment in Performance III Direct Transcarotid Access Stenting Trial October 6, 2023 Read More ›
Thryv Therapeutics announces FDA clearance for Phase 1 Study of THRV-1257 in Anaplastic Thyroid Cancer and acceptance of Late-Breaking Poster Presentation at American Thyroid Association Meeting. August 15, 2023 Read More ›
